(February 20, 2019, 8:23 AM EST) -- PENSACOLA, Fla. — The Florida federal judge presiding over the Abilify multidistrict litigation on Feb. 15 ordered a Feb. 20 case management conference after the parties on Feb. 15 told the court that they entered into a confidential master settlement agreement establishing a proposed settlement program to resolve all federal and state claims that the atypical antipsychotic drug Abilify causes compulsive behavior such as gambling (In Re: Abilify [Aripiprazole] Products Liability Litigation, MDL Docket No. 2734, No 16-md-2734, N.D. Fla., Pensacola Div.)....